Navigation Links
Florida EMS and Fire Vehicles to Stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE ("Cyanokit") for Cyanide Poisoning
Date:5/29/2008

- State officials desire quick-response emergency capability to treat

suspected and known cyanide poisoning -

NAPA, Calif., May 29 /PRNewswire/ -- Dey, L.P. today announced that the Florida Department of Health, Office of Emergency Operations, will stock Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE for Cyanide Poisoning in the State's emergency medical service (EMS) and fire vehicles through a federal grant from the Department of Homeland Security. As the only FDA-approved treatment that can be given to victims of suspected cyanide poisoning, Cyanokit provides emergency first-responders with a critical care medication to treat patients immediately at the scene of a fire or other accident as well as in a hospital emergency room.(1)

Studies have shown that cyanide, a common but often unrecognized toxic chemical found in fire smoke, may play a significant role in causing the deaths of smoke inhalation victims.(2) In the United States, smoke inhalation is responsible for up to 10,000 civilian and firefighter deaths and more than 20,000 injuries annually.(3)(4)

"It is critical that we do whatever we can to enhance the safety of Florida's first response personnel and the victims they care for in emergencies involving potential exposure to cyanide," said Dr. Joe Nelson, State EMS Medical Director. "Because cyanide poisoning acts very quickly, the immediate quick response capability that Cyanokit provides at the scene of an emergency will be critical in treating known or suspected victims of cyanide poisoning. Inclusion of Cyanokit in our EMS and fire vehicles will help protect both our emergency first responders and Florida's citizens."

"Florida's stocking of Cyanokit in its EMS and fire vehicles reflects a recognition by State officials that first responders need to be prepared to treat cyanide poisoning immediately in an emergency," said Carolyn Myers, Ph.D., President of Dey, L.P. "The ability to treat suspected cases of cyanide poisoning at the scene of a fire or other accident gives potential victims a much-needed measure of safety when survival can be measured in minutes."

About Cyanokit(R) 5g (hydroxocobalamin for injection) ANTIDOTE(1)

Cyanokit is indicated for the treatment of known or suspected cyanide poisoning. If clinical suspicion of cyanide poisoning is high, Cyanokit should be administered without delay.

Important Safety Information

Prior to administration of Cyanokit, smoke-inhalation victims should be assessed for: exposure to fire or smoke in an enclosed area; presence of soot around the mouth, nose or oropharynx; altered mental status.

Use caution in the management of patients with known anaphylactic reactions to hydroxocobalamin or cyanocobalamin. Allergic reactions may include: anaphylaxis, chest tightness, edema, urticaria, pruritus, dyspnea, and rash.

Most common adverse reactions (>5%) are transient and include chromaturia (red-colored urine), erythema (skin redness), rash, increased blood pressure, nausea, headache, decreased lymphocyte percent, and injection site reactions. Usage may interfere with some clinical laboratory evaluations.

If the decision is made to administer another antidote with Cyanokit, these drugs should not be administered in the same IV line. The safety of simultaneous administration has not been established.

Please see full Prescribing Information at http://www.cyanokit.com or call 800-755-5560 and ask for Customer Service.

About Dey, L.P.

Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, respiratory-related allergies, and emergency care medicine. As the U.S. leader in sales of nebulized respiratory medication, Dey, L.P. puts patients first through its development of innovative and affordable therapies. The Web sites for Dey, L.P. include http://www.dey.com, http://www.accuneb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, http://www.epipen.com and http://www.perforomist.com.

Cyanokit is a registered trademark of Merck Sante s.a.s. Cyanokit is distributed exclusively in the United States by Dey, L.P. of Napa, CA.

Media Contacts:

Dey, L.P. Media Line

800-755-5560, ext. 8363

OR

Nicole Arens

Ogilvy Public Relations Worldwide

202-729-4069

Nicole.arens@ogilvypr.com

References

1 Full Prescribing Information for Cyanokit.

2 "Report of the Investigation Committee into the Cyanide Poisonings of

Providence Firefighters," May 30, 2006.

3 "Cyanide: Understanding the Risk, Enhancing Preparedness, RTI

International," Clinical Toxicology 47-63.

4 Inna Leybell, "Toxicity, Cyanide," Emedicine from WebMD,

http://www.emedicine.com/emerg/topic118.htm (last updated May 18, 2006).


'/>"/>
SOURCE Dey, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. James Zingale Joins Safety Net Hospital Alliance of Florida
2. Registration Ends This Week: Fortune 500 Networking & Best Practice Sharing Conference in Florida
3. Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrows Leaders
4. The Blue Foundation for a Healthy Florida Announces $8 Million Initiative to Address Childhood Obesity
5. Florida Hospital Group Pays U.S. $7,775,000 to Settle False Claims Act Allegations
6. David Pizzo Appointed Blue Cross and Blue Shield of Florida Market President - West Florida
7. Florida Cardiology Chooses Intergy by Sage to Integrate Practice Management and Electronic Health Records
8. Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida
9. MedeFile and Dr. Lorne Stitsky Host Open House at Personal Choice Family Practice in Jupiter, Florida
10. Blue Cross and Blue Shield of Florida Invites Floridians to Step Up to the Microphone and Talk Health Care
11. Weeping Image of Jesus at Florida Hospital Explained
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... to catalyze conversations in support of bold systems change models helping to achieve ... an event on September 21, 2017, “We the Future: Accelerating Sustainable Development Solutions” ...
(Date:8/17/2017)... ... August 17, 2017 , ... SeQuel Response announced today that for ... among the fastest-growing private companies in the U.S., putting it in the top 10 ... applied to the Inc. 5000 over the years, only a fraction have ...
(Date:8/17/2017)... ... 2017 , ... Dr. Charles W. Grimsley’s new book ... 9781498497626; $7.99, eBook, 9781498497633) focuses on the treatment of veterans diagnosed with posttraumatic ... through a progressive journey toward healing. This book will help readers learn to ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC recently ... is a member of the firm’s Commercial Litigation and Employment Law groups. , Ms. ... of knowledge in matters of employment litigation, commercial litigation and business disputes. Her experience ...
(Date:8/17/2017)... ... August 17, 2017 , ... A recent report indicates that circa 79 percent ... cited deficiencies in data integrity. The FDA outlines their expectations for quality critical instrumentation ... as part of the Beckman Coulter Life Sciences Virtual Trade Show Virtual ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/4/2017)... 4, 2017 The search for test results ... physician/patient consult has long been the goal of healthcare ... focus of the largest meeting of lab professionals and ... market research firm Kalorama Information.  The firm said scores ... or related supplies and software were at the American ...
Breaking Medicine Technology: